AQUAPASS Completes Pivotal Trial Enrollment for ECCON System
Newton, Massachusetts, USA & Shefayim, Israel, August 10, 2026 AQUAPASS, Inc. has announced the completion of enrollment in its...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Newton, Massachusetts, USA & Shefayim, Israel, August 10, 2026 AQUAPASS, Inc. has announced the completion of enrollment in its...
Mumbai, India & Naples, Florida, USA, August 10, 2026 Lupin Limited has announced that it has received U.S. Food...
Seoul, South Korea, August 10, 2026 Seegene Inc. has announced a comprehensive approach to syndromic PCR screening for reproductive...
Seoul, South Korea, August 5, 2026 Seegene Inc., a global leader in molecular diagnostics, has unveiled a comprehensive PCR-based...
NORWOOD, Mass., July 28, 2026 Corbus Pharmaceuticals Holdings, Inc. has received U.S. Food and Drug Administration (FDA) clearance to...
TOKYO, July 22, 2026 Kirin Holdings Company, Limited and Blackmores Limited have announced the launch of two new Cognizin®...
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has announced a comprehensive Syndromic...
Plymouth Meeting, Pennsylvania, USA – May 21, 2026 INOVIO Pharmaceuticals and its China-based partner ApolloBio announced positive topline results...
